Telix Pharmaceuticals | TLX - Cash And Equivalent



Telix Pharmaceuticals reported 710.35M in Cash and Equivalent for its fiscal semester ending in December of 2024.


Cash And Equivalent Change Date
Cochlear AUD 383.1M 130.5M Dec/2024
CSL 1.52B 133M Dec/2024
Integral Diagnostics 17.99M 15.86M Dec/2023
Mayne Pharma 110.07M 838K Jun/2024
Medical Developments International AUD 17.62M 7.88M Dec/2024
Mesoblast 62.56M 14.58M Jun/2024
Neuren Pharmaceuticals AUD 3.15M 582K Dec/2024
Pacific Edge NZD 22.57M 637K Mar/2025
Paradigm Biopharmaceuticals 17.82M 15.73M Jun/2024
Polynovo 45.91M 330K Jun/2024
PYC Therapeutics AUD 49.25M 17.62M Dec/2024
Ramsay Health Care AUD 341.1M 321.2M Dec/2024
ResMed USD 1.21B 687.51M Jun/2025
Sonic Healthcare 645M 25.39M Jun/2024